Hikma Pharmaceutical | HIK - Выручка от реализации





Продажи Изменить Дата
Almirall EUR 547.63M 12.83M 2025-12
argenx SE USD 1.12B 0 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Autolus Therapeutics Ltd USD 26.22M 1.93M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
Fresenius EUR 5.74B 140M 2026-03
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
GRIFOLS EUR 1.7B 280M 2026-03
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Orion EUR 417.7M 277.6M 2026-03
Recordati EUR 713.42M 51.42M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12